Overview

Study of Pomaglumetad and Methamphetamine

Status:
Terminated

Trial end date:
2020-07-31

Target enrollment:

Participant gender:

Summary

This is the first study of pomaglumetad in humans using methamphetamine. The goal of the study is to determine if pomaglumetad is safe when administered with methamphetamine. If shown to be safe with methamphetamine in the current study, a phase 2 clinical trial of pomaglumetad would be done to begin to find out if pomaglumetad is effective in treating methamphetamine use disorder.

Phase:

Phase 1

Details

Lead Sponsor:

University of California, Los Angeles

Collaborator:

National Institute on Drug Abuse (NIDA)

Treatments:

Methamphetamine